Mazurov Vi

Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

Mark C. Genovese, Patrick Durez, Hanno B. Richards et al. · Annals of the Rheumatic Diseases · 2012 · 288 citations

Life Sciences, Immunology, Pharmacotherapy +17

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

Joachim Sieper, Jan Lenaerts, J. Wollenhaupt et al. · Annals of the Rheumatic Diseases · 2013 · 213 citations · Full text

Medicine, Pharmacotherapy, Pain Management +16

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

Joachim Sieper, Jan Lenaerts, J. Wollenhaupt et al. · Annals of the Rheumatic Diseases · 2013 · 64 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee

Robert M. Levy, S S Kopenkin, B. Ya. Bart et al. · Advances in Therapy · 2010 · 57 citations

Medicine, Orthopedic Surgery, Pharmacology +8